Evidence map›Paper›PMID 36937235›Full record

ArticleEuropean heart journal. Case reports2023

Second-generation robotic angioplasty system use for the treatment of ST-elevation myocardial infarction: a first-in-man proof of concept case report.

Felix J Hofmann, Oliver Dörr, Florian Blachutzik, Albrecht Elsässer, Helge Möllmann, Alessa-Janine Köhne, Holger M Nef

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal. Case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Felix J HofmannDepartment of Cardiology and Angiology, University Hospital of Giessen and Marburg, Klinikstraße 33, 35392 Giessen, Germany.ORCID https://orcid.org/0000-0002-5395-3652
Oliver DörrDepartment of Cardiology and Angiology, University Hospital of Giessen and Marburg, Klinikstraße 33, 35392 Giessen, Germany.
Florian BlachutzikDepartment of Cardiology and Angiology, University Hospital of Giessen and Marburg, Klinikstraße 33, 35392 Giessen, Germany.
Albrecht ElsässerDepartment of Cardiology, Klinikum Oldenburg, Rahel- Straus-Straße 10 26133 Oldenburg, Germany.
Helge MöllmannDepartment of Internal Medicine, St. Johannes-Hospital, Johannesstraße 9-13, 44137 Dortmund, Germany.
Alessa-Janine KöhneDepartment of Cardiology and Angiology, University Hospital of Giessen and Marburg, Klinikstraße 33, 35392 Giessen, Germany.
Holger M NefDepartment of Cardiology and Angiology, University Hospital of Giessen and Marburg, Klinikstraße 33, 35392 Giessen, Germany.
Universitätsklinikum Gießen und Marburg · DEKlinikum Oldenburg · DESt.-Johannes-Hospital Dortmund · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Robotically assisted remote-controlled PCI (rPCI) was introduced in the past decade as one of the latest enhancements in this rapidly evolving field. The use of a second-generation rPCI system in ST-elevation myocardial infarction (STEMI) is an effort to couple immediate revascularization with the accuracy of newer robotic assistance and software support. Case summary: Here we report on the safety and efficacy of rPCI applied to a 74-year-old female STEMI patient with persistent acute chest pain as well as regional wall motion abnormalities in the echocardiogram. The first medical contact-to-device time was 76 min, and door-to-balloon time was 33 min. The impatient course was uneventful, so the patient was discharged from hospital after 5 days. To the best of our knowledge, this is the first report of the successful application of second-generation rPCI in STEMI. Discussion: In the case presented, rPCI was feasible and safe even in acute coronary syndrome based on a single-centre experience. rPCI is a revolutionary new technique that may be applied to various types of clinical presentations.

Indexed as

Acute coronary syndromeCase reportCoronary heart diseaseRobotic PCI (rPCI)

Identifiers

PMID36937235
PMCPMC10015801
OpenAlexW4323356657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.